Paper22611237
A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion.
Lee H and 7 others. J Immunol, 2012. Cited by 12 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion. Papers, record 22611237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22611237
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| B-Lymphocytes | Major topic |
| Immunity, Innate | Major topic |
| Lymphocyte Activation | Major topic |
| Signal Transduction | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Animals | |
| Apoptosis | |
| B-Cell Activating Factor | |
| Cell Proliferation | |
| Humans | |
| Interleukin-4 | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Mutant Strains | |
| RNA, Small Interfering | |
| Receptors, Antigen, B-Cell | |
| Reverse Transcriptase Polymerase Chain Reaction |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| M01 RR018535 | NCRR NIH HHS | United States | M01RR018535 | PubMed and NIH | NIH RePORTER |
| R01 AI052189 | NIAID NIH HHS | United States | R01AI052189 | PubMed and NIH | NIH RePORTER |
| Intramural NIH HHS | United States | PubMed | PubMed | ||
| M01 RR018535 | NCRR NIH HHS | United States | M01RR018535 | PubMed and NIH | NIH RePORTER |
References127
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16709833 | APRIL and BAFF promote increased viability of replicating human B2 cells via mechanism involving cyclooxygenase 2. | J Immunol | 2006 | https://conductscience.org/library/papers/16709833 | PubMed |
| 2 | 17558410 | Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR. | Nat Immunol | 2007 | https://conductscience.org/library/papers/17558410 | PubMed |
| 3 | 9226177 | Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. | Blood | 1997 | https://conductscience.org/library/papers/9226177 | PubMed |
| 4 | 12402042 | BID regulation by p53 contributes to chemosensitivity. | Nat Cell Biol | 2002 | https://conductscience.org/library/papers/12402042 | PubMed |
| 5 | 18025197 | Transgenic expression of Bcl-xL or Bcl-2 by murine B cells enhances the in vivo antipolysaccharide, but not antiprotein, response to intact Streptococcus pneumoniae. | J Immunol | 2007 | https://conductscience.org/library/papers/18025197 | PubMed |
| 6 | 1552940 | Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. | Nature | 1992 | https://conductscience.org/library/papers/1552940 | PubMed |
| 7 | 19265126 | T-independent antibody responses to T-dependent antigens: a novel follicular dendritic cell-dependent activity. | J Immunol | 2009 | https://conductscience.org/library/papers/19265126 | PubMed |
| 8 | 16166262 | miR-15 and miR-16 induce apoptosis by targeting BCL2. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/16166262 | PubMed |
| 9 | 21127253 | BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program. | Science | 2010 | https://conductscience.org/library/papers/21127253 | PubMed |
| 10 | 19641510 | Bid: a Bax-like BH3 protein. | Oncogene | 2008 | https://conductscience.org/library/papers/19641510 | PubMed |
| 11 | 22213803 | The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis. | J Exp Med | 2012 | https://conductscience.org/library/papers/22213803 | PubMed |
| 12 | 16801400 | FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal. | J Exp Med | 2006 | https://conductscience.org/library/papers/16801400 | PubMed |
| 13 | 16461747 | p53 regulates Btk-dependent B cell proliferation but not differentiation. | J Leukoc Biol | 2006 | https://conductscience.org/library/papers/16461747 | PubMed |
| 14 | 17312102 | Cutting Edge: Bim is required for superantigen-mediated B cell death. | J Immunol | 2007 | https://conductscience.org/library/papers/17312102 | PubMed |
| 15 | 15989956 | ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. | Cell | 2005 | https://conductscience.org/library/papers/15989956 | PubMed |
| 16 | 18263783 | Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. | Blood | 2008 | https://conductscience.org/library/papers/18263783 | PubMed |
| 17 | 19935675 | Awakening guardian angels: drugging the p53 pathway. | Nat Rev Cancer | 2009 | https://conductscience.org/library/papers/19935675 | PubMed |
| 18 | 8018922 | Frequent p53 gene involvement in splenic B-cell leukemia/lymphomas of possible marginal zone origin. | Blood | 1994 | https://conductscience.org/library/papers/8018922 | PubMed |
| 19 | 10801801 | Ubiquitin-mediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10801801 | PubMed |
| 20 | 19088870 | Resistance to rituximab therapy and local BAFF overexpression in Sjögren's syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphoma. | Open Rheumatol J | 2008 | https://conductscience.org/library/papers/19088870 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39664277 | BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism. | Lymphatics | 2024 | https://conductscience.org/library/papers/39664277 | PubMed |
| 37966267 | The Proteasome Inhibitor Bortezomib Induces p53-Dependent Apoptosis in Activated B Cells. | J Immunol | 2024 | https://conductscience.org/library/papers/37966267 | PubMed |
| 33808645 | CD19 Chimeric Antigen Receptor-Exosome Targets CD19 Positive B-lineage Acute Lymphocytic Leukemia and Induces Cytotoxicity. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33808645 | PubMed |
| 31508424 | Cooperation of Oligodeoxynucleotides and Synthetic Molecules as Enhanced Immune Modulators. | Front Nutr | 2019 | https://conductscience.org/library/papers/31508424 | PubMed |
| 30988120 | Mechanism for IL-15-Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response Proteins. | J Immunol | 2019 | https://conductscience.org/library/papers/30988120 | PubMed |
| 30068596 | Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal Expansion. | J Immunol | 2018 | https://conductscience.org/library/papers/30068596 | PubMed |
| 26682236 | The Role of Aggregates of Therapeutic Protein Products in Immunogenicity: An Evaluation by Mathematical Modeling. | J Immunol Res | 2015 | https://conductscience.org/library/papers/26682236 | PubMed |
| 26136429 | TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells. | J Immunol | 2015 | https://conductscience.org/library/papers/26136429 | PubMed |
| 24145719 | Effects of prostaglandin E2 on p53 mRNA transcription and p53 mutagenesis during T-cell-independent human B-cell clonal expansion. | FASEB J | 2014 | https://conductscience.org/library/papers/24145719 | PubMed |
Genes31
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22611237
GET https://conductscience.org/api/papers/v1/22611237/references?page=2